NCT04899921 2024-03-26
Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
Dana-Farber Cancer Institute
Phase 2 Terminated
Clinical Trials
12 trialsNCT02055963 2022-10-20
Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02137252 2021-11-16
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT00354432 2021-09-28
Soy Protein/Effexor Hormone Therapy for Prostate Cancer
Wake Forest University Health Sciences
Phase 3 Terminated
NCT02285855 2020-01-06
Metformin in Non Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02012608 2019-05-29
Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy
University of Arkansas
Phase 2 Terminated
NCT00206440 2018-12-06
NEXIUM
Baylor Breast Care Center
Phase 3 Terminated
NCT02018653 2018-07-26
CASAD for Severe Diarrhea in the Emergency Department
M.D. Anderson Cancer Center
Phase NA Terminated
NCT02360059 2017-08-17
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00995722 2017-06-02
EPITOME'
University of Miami
Phase 3 Terminated
NCT00785356 2014-08-21
Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 3 Terminated
NCT00936598 2014-04-24
Sleep and Endometrial Cancer
University of Pittsburgh
Phase NA Terminated